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by 2 to 4 days of preoperative meta-
bolic therapy with oral orotic acid as
a means of protecting the recently in-
farcted heart during emergency cardiac
surgery. Orotic acid is a pyrimidine
precursor that can augment the rate of
synthesis of RNA, proteins, and glyco-
gen. Pretreatment with orotic acid, in
animal models, improves the func-
tional recovery of the infarcted heart
after cardioplegic arrest (43% recovery
of prearrest function in orotic acid–treated
groups compared with 18% in untreated
groups; P< .001).3
In conclusion, the results of Miya-
hara and associates are promising and
provide practical evidence for the ben-
efits of avoiding crossclamping of the
aorta. These benefits can best be ex-
plained by an improved understanding
of the changes that occur in the remote,
noninfarcted myocardium. We have
shown that these changes can be atten-
uated by preoperative metabolic ther-
apy with orotic acid. We propose that
the use of the OPBH technique, com-
bined with metabolic strategies, could
result in better recovery in patients un-
dergoing cardiac surgery after MI than
with either technique alone and could
allow cardiac surgery after recent MI
to be performed even more safely and
effectively.
Kapilan Varatharajah
Franklin L. Rosenfeldt, MD, FRACS
The Alfred CJOB Cardiothoracic
Surgery
Prahran, Victoria, Australia
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FIGURE 1. Myocardium after coronary artery occlusion. The infarcted myocardium is necrotic and
akinetic. The larger noninfarcted myocardium undergoes physiologic and biochemical changes.
ATP, Adenosine triphosphate; CP, creatine phosphate; MVO2, myocardial oxygen consumption.
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We appreciate the comments of
Varatharajah and Rosenfeldt on our
article, ‘‘On-Pump Beating-Heart
Coronary Artery Bypass Grafting After
Acute Myocardial Infarction Has Lower
Mortality and Morbidity.’’1 The com-
ments indicate the importance of pre-
serving the function of noninfarcted
myocardium, which is highly suscep-
tible to the effects of ischemia, and
represent theoretical grounds for the
benefits of avoiding reperfusion injury
after crossclamping the aorta during cor-
onary artery bypass grafting (CABG) in
acute myocardial infarction (AMI).d Cardiovascular Surgery c June 2009We are impressed by the fact that
the metabolic2 and structural3 changes
in the myocardium after infarction
were investigated many years ago dur-
ing the early stages of cardiac surgery.
We have treated another 45 patients
with AMI since our report and have ap-
plied this technique consistently. The
results have been excellent, with an
overall hospital mortality of 2.2%.
The only patient who died had a left
main trunk infarction and required per-
cutaneous cardiopulmonary support
preoperatively. We confirmed the reli-
ability of this technique. Technological
advances in devices such as a suction
stabilizer, apical suction cardiac posi-
tioning device, intravascular shunt,
and temporary occlusion device enable
us to perform on-pump beating-heart
surgery reliably and safely.
To save these critically ill patients,
in addition to avoiding cardioplegic ar-
rest, we would like to emphasize the
need for cardiopulmonary bypass to
compensate the residual myocardial
function and visceral organ failure.
We know little about orotic acid. On
the basis of experimental findings in
dogs,4 it is attractive and may help to
improve the results. In our series of pa-
tients with AMI, the mean time inter-
val from the onset of AMI to CABG
was 18 hours. Therefore, orotic acid
can be administered only during the
few hours that are available between
admission and surgery, allowing one
or two doses at most. Further study is
required to determine whether preop-
erative metabolic therapy with oral or-
otic acid is effective in this clinical
setting.
In summary, on-pump beating-heart
CABG is the best form of surgical
treatment for patients with AMI.
Ken Miyahara, MD
Akio Matsuura, MD
Haruki Takemura, MD
Shunei Saito, MD
Aichi Cardiovascular and
Respiratory Center
Division of Cardiovascular Surgery
Ichinomiya, Aichi, Japan
aortic endocarditis, acute aortic dissec-
tions, and mechanical complications
of an acute myocardial infarction.
The latter, like postinfarction ventricu-
lar free wall rupture, could be better
managed with an on-pump beating
heart operation to reduce the ische-
mia–reperfusion injury2 caused by car-
dioplegic arrest in patients with recent
or ongoing acute coronary syndromes.
Nevertheless, we are a little concerned
with the technique described in Kilian
and coworkers’ article.1
The authors perform ICAN during
cardioplegic arrest of the heart; this re-
sults in prolonged crossclamp time
sternal retractors and aortic clamps.
Third, it can be done during on-pump
beating heart operations. Finally, it pro-
vides views similar to those obtained
with a conventional study that, conse-
quently, are more easily interpretable.
Augusto D’Onofrio, MDa
Giovanni Domenico Cresce, MDa
Luigi La Vecchia, MDb
Alessandro Fabbri, MDa
Divisions of Cardiac Surgerya and
Cardiologyb
San Bortolo Hospital
Vicenza, Italy
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ANGIOGRAPHY: WITH OR
WITHOUT ISCHEMIA?
To the Editor:
We read with interest the article by
Kilian and coworkers1 entitled ‘‘Intra-
operative coronary angiography in the
management of patients with acute
aortic dissection and endocarditis.’’
The authors describe the possibility
of performing an intraoperative angio-
graphic assessment of the coronary
arteries in patients with potential
contraindications to the conventional
preoperative cardiac catheterization
in the catheterization laboratory. In
fact, in patients presenting with acute
aortic dissection, the diagnosis is usu-
ally accomplished by means of com-
puted tomographic scanning and
transesophageal echocardiographic
analysis, and the patient is immedi-
ately moved to the operating room
for emergency surgical intervention.
In such a setting, conventional cardiac
catheterization is time consuming and
could generate a harmful delay to in-
tervention. Furthermore, patients with
aortic valve endocarditis with vegeta-
tions are at high risk of embolization
during cardiac catheterization.
We agree with the authors about the
feasibility and efficacy of this diag-
nostic strategy, and we commonly use
intraoperative coronary angiography
(ICAN) in the following situations:
and, consequently, longer myocardial
ischemia. This is particularly true if
the coronary lesions are not easily de-
tectable and several different projec-
tions are needed. Furthermore, this
technique cannot be performed in pa-
tients undergoing an on-pump beating
heart operation. Thus we strongly be-
lieve that ICAN should be carried out
through a femoral artery access with
the heart beating after aortic cross-
clamp removal and before weaning
from cardiopulmonary bypass (CPB)
or decannulation. In particular, in pa-
tients undergoing operations on the
aortic valve, the ascending aorta, or
both, ICAN can be safely performed
after that the procedure is completed
and the aortic clamp is removed. If cor-
onary lesions are found, off-pump cor-
onary artery bypass or, if that is not
possible, on-pump beating heart coro-
nary artery bypass grafting can be
performed, thus resulting in less
myocardial ischemia, shorter CPB
duration, or both. Furthermore, addi-
tional information other than the coro-
nary mold could be obtained with the
beating heart technique: speed of con-
trast washout, milking effects, and,
most of all, a more physiologic view
of the coronary anatomy.
In conclusion, we believe that per-
forming ICAN with the heart beating
has several advantages. First, it does
not increase crossclamp and CPB
times. Second, it can be performed
without many interferences, such as
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Reply to the Editor:
We appreciate the response to our
article ‘‘Intraoperative Coronary Angi-
ography in the Management of Patients
With Acute Aortic Dissection and En-
docarditis’’ and thank D’Onofrio and
colleagues for their interest in the de-
scribed intraoperative angiographic
technique. As mentioned in their Letter
to the Editor, the authors discuss the
prolongation of myocardial ischemia
while performing intraoperative coro-
nary angiography (ICA) during aortic
crossclamping (ACC) instead of per-
forming ICA after removal of the aortic
clamp via a peripheral artery, as de-
scribed in their case report2 of a patient
presenting with an ischemic rupture of
the left ventricular lateral wall. We
agree that ischemia should be reduced
as much as possible and that performing
ICA during the reperfusion period is
a good alternative, but we wanted to
avoid this approach for our patients.1
We intended to intubate the coronary
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